Literature DB >> 19876795

Medical antihyperglycaemic treatment of type 2 diabetes mellitus: update of the evidence-based guideline of the German Diabetes Association.

S Matthaei, R Bierwirth, A Fritsche, B Gallwitz, H-U Häring, H-G Joost, M Kellerer, Ch Kloos, T Kunt, M Nauck, G Schernthaner, E Siegel, F Thienel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19876795     DOI： 10.1055/s-0029-1239559

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN： 0947-7349            Impact factor:   2.949


× No keyword cloud information.
  36 in total

1.  Effect of pioglitazone and ramipril on biomarkers of low-grade inflammation and vascular function in nondiabetic patients with increased cardiovascular risk and an activated inflammation: results from the PIOace study.

Authors:  Andreas Pfützner; Markolf Hanefeld; Lida A Dekordi; Jürgen Müller; Iris Kleine; Winfried Fuchs; Thomas Forst
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

2.  Impact of Disease Management Programs on HbA1c Values in Type 2 Diabetes Patients in Germany.

Authors:  Karel Kostev; Timo Rockel; Louis Jacob
Journal:  J Diabetes Sci Technol       Date:  2016-07-10

Review 3.  The treatment of type 2 diabetes.

Authors:  Andreas F H Pfeiffer; Harald H Klein
Journal:  Dtsch Arztebl Int       Date:  2014-01-31       Impact factor: 5.594

4.  Cost effectiveness of saxagliptin and metformin versus sulfonylurea and metformin in the treatment of type 2 diabetes mellitus in Germany: a Cardiff diabetes model analysis.

Authors:  Wilma Erhardt; Klas Bergenheim; Isabelle Duprat-Lomon; Phil McEwan
Journal:  Clin Drug Investig       Date:  2012-03-01       Impact factor: 2.859

Review 5.  Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe--recommendations from the international Central-Eastern European expert group.

Authors:  Leszek Czupryniak; László Barkai; Svetlana Bolgarska; Agata Bronisz; Jan Broz; Katarzyna Cypryk; Marek Honka; Andrej Janez; Mladen Krnic; Nebojsa Lalic; Emil Martinka; Dario Rahelic; Gabriela Roman; Tsvetalina Tankova; Tamás Várkonyi; Bogumił Wolnik; Nadia Zherdova
Journal:  Diabetes Technol Ther       Date:  2014-04-09       Impact factor: 6.118

Review 6.  Benefit-risk assessment of exenatide in the therapy of type 2 diabetes mellitus.

Authors:  Baptist Gallwitz
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

Review 7.  Do We Need Updated Guidelines on the Use of Insulin Pump Therapy in Type 2 Diabetes? A Review of National and International Practice Guidelines.

Authors:  Ohad Cohen; William Valentine
Journal:  J Diabetes Sci Technol       Date:  2016-11-01

Review 8.  The evolving place of incretin-based therapies in type 2 diabetes.

Authors:  Baptist Gallwitz
Journal:  Pediatr Nephrol       Date:  2010-02-04       Impact factor: 3.714

9.  Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline.

Authors:  Peter Bramlage; Christiane Binz; Anselm K Gitt; Michael Krekler; Tanja Plate; Evelin Deeg; Diethelm Tschöpe
Journal:  Cardiovasc Diabetol       Date:  2010-09-16       Impact factor: 9.951

10.  Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis.

Authors:  G Schernthaner; A H Barnett; D J Betteridge; R Carmena; A Ceriello; B Charbonnel; M Hanefeld; R Lehmann; M T Malecki; R Nesto; V Pirags; A Scheen; J Seufert; A Sjohölm; A Tsatsoulis; R DeFronzo
Journal:  Diabetologia       Date:  2010-03-31       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.